Archives: Investor Centre

Entitlement Offer Letter to Ineligible Shareholders

Investor Presentation September 2020

Appendix 4G & Corporate Governance Statement

Corum Executive Management Changes

Corum New Company Secretary Appointment

Acquisition of Remaining 57% interest in PharmX

Appendix 3B – Performance Rights Issues

Corum Group Annual Report 2020

Director Resignation and Final Director’s Interest Notice

Update on BAMM Agreement